Noah Goodman - Chief Business Officer at Kymera Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Issuer Symbol
KYMR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Noah Goodman since 10 Mar 2025

Holdings reported by Noah Goodman for Kymera Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 59,306 $4,982,926 $84.02 02 Mar 2026 Direct
Stock Option (Right to Buy) 18,450 02 Mar 2026 Direct Common Stock

Transactions reported by Noah Goodman for Kymera Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.